Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > If you voted yes to this group then…
View:
Post by Dumbeldorfwhite on May 30, 2024 8:17pm

If you voted yes to this group then…

You 're a fool. Here we are again with the boys trying to spin things. The market clearly doesn't believe in this team. Somehow the efficacy numbers seem to be getting worse.
Comment by DeathXray33 on May 31, 2024 11:41am
@ > 1.412 now :-)
Comment by reconsider on Jun 03, 2024 2:48pm
Where are the efficacy numbers getting worse?
Comment by DJDawg on Jun 03, 2024 3:06pm
They are not getting worse really. Anytime you have a NR patient and they withdraw from trial then they immediately become NR at 90,180,270,360,450 days So in one fell swoop an NR can ripple out and drop the efficacy numbers across the board. Meanwhile CR's have to go one timepoint at a time. So there have been a few early NR's lately that have swung into the full NR 90 to 450 category ...more  
Comment by Dumbeldorfwhite on Jun 03, 2024 3:32pm
Pretty simple just read the quarterly's . Used to be 37 percent now down to 30
Comment by Kayz88 on Jun 03, 2024 6:32pm
Ah man...Previous 450 days was 43% and now it's 36% (Optimized) - To that same token, there's 5 more NR than before, so might be okay?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250